Pharmaceuticals
Quest Diagnostics to buy Solstas Lab for $570 mn
23 Jan 2014
Aurobindo Pharma to acquire Actavis’s European operations
18 Jan 2014
Aurobindo Pharma will acquire the generics commercial operations of Actavis Plc in seven markets across Western Europe
J&J to sell Ortho Clinical Diagnostics unit to Carlyle for $4.15 bn
17 Jan 2014
US healthcare major Johnson & Johnson (J&J) yesterday agreed to sell its Ortho Clinical Diagnostics (OCD) unit to private equity firm Carlyle Group for $4.15 billion.
Sanofi unit Genzyme in alliance with Alnylam Pharmaceuticals to develop RNAi therapeutics
13 Jan 2014
Novartis arm faces criminal case in Japan over exaggerated advertising
09 Jan 2014
Under Japanese law, anyone found guilty of exaggerated advertising can be punished with up to two years in prison or a fine of as much as ¥2 million
Forest Labs acquires Aptalis for $2.9 bn
09 Jan 2014
The acquisition of Aptalis will help diversify Forest's pharmaceuticals portfolio while advancing its strategy to create blockbuster therapeutics
Thermo Fischer to sell cell research business to GE for over $1 bn
07 Jan 2014
The world’s second-largest laboratory equipment and supplies provider Thermo Fischer Scientific Inc will sell its cell research business to GE Healthcare for $1.06 billion,to gain EC’s approval for is acquisition of rival Life Technologies
Drug companies in UK not sharing complete information on clinical trials with doctors: MPs
04 Jan 2014
Sanofi fails to win US FDA approval for Genzyme's MS drug Lemtrada
30 Dec 2013
The drug, which gained approval in the EU in September, and in Australia and Canada this month, formed a key part of Sanofi’s $20.1-billion acquisition of Genzyme in 2011
AstraZeneca to acquire Bristol-Myers Squibb’s stake in diabetes business
20 Dec 2013
The acquisition will boost AstraZeneca's presence in the emerging markets, where diabetes is a fast-growing problem and by 2030, is expected to accout of two-thirds of the world's diabetic population
S Korean companies Hanmi and Amneal Pharm launch first copy of AstraZeneca's Nexium in US
20 Dec 2013
Bayer to acquire cancer drug maker Algeta
19 Dec 2013
Bayer and Algeta are partners in the sale of the prostate cancer drug Xofigo, which the US FDA had approved in May
GlaxoSmithKline to stop paying doctors for product promotion
17 Dec 2013
The move comes after the biggest drugmaker in the UK stood accused of making corrupt payments to doctors and officials to boost its drug sales in China
Featured articles
Lighter than air, yet very, very powerful
By Kiron Kasbekar | 03 Jan 2024
In March 2013 Chinese scientists pulled off a remarkable feat. They created the world’s lightest aerogel. Tipping the scales at a mere 0.16 milligrams per cubic centimeter – that’s a sixth of the weight of air!
COP28 explained: A closer look at COP28's climate change solutions
By Aniket Gupta | 27 Dec 2023
The 28th United Nations Climate Change Conference, also known as COP28, took place from 30th November 2023, to 13th December 2023, at Expo City in Dubai, United Arab Emirates.
What is a Ponzi scheme?
By Aniket Gupta | 06 Dec 2023
Ponzi schemes have long captivated the public imagination, drawing unsuspecting investors into a web of illusion and deception.
The Rise and Rise of HDFC Bank
03 Jul 2023
HDFC, which surged ahead of global majors like HSBC Holdings Plc and Citigroup Inc and left Indian peers like State Bank of India and ICICI Bank in market capitalisation, now ranks fourth largest among the world’s most valuable banks, after JPMorgan Chase & Co, Industrial and Commercial Bank of China Ltd and Bank of America Corp
India’s Millet Revolution To Enrich Global Food Basket
02 Apr 2023
Millets, a healthier and cheaper substitute to wheat and rice, are indigenous to many parts of the world, especially in the semiarid tropics of Asia and Africa, and offers a big scope for expanding production and consumption in the foodgrain deficient African continent
Market predator Hindenburg preys on Adani stock
06 Mar 2023
Almost a month after the damning report of short-seller Hindenburg Research on the Adani Group that claimed that the seven stocks within the group were about 85 per cent overvalued, one of the group's stocks, Adani Total Gas, closed at Rs835 on the BSE, down nearly 79 per cent from its 24 January level, almost close to reaching that valuation
.jpg "CBDT explains Budget proposal on capital gains tax")
.jpg "Economic Survey projects India’s GDP growth at 6.5–7% in 2024-25")
.jpg "Adani-Sirus joint venture to acquire 77.5% stake in Coredge.io parent Parserlabs")
